News summary

Age Acceleration in Various Proteomic Clocks Correlates with Risk of Mortality and Age-Related Disease

Source: Fight Aging! • Published: 08 Sept 2026, 10:10

Summarized by Masters of Longevity from Fight Aging!.

Proteomic-aging research exploring multiple blood-based clocks and organ-specific signatures, offering readers insight into a biomarker-focused study on aging and disease risk.

Age Acceleration in Various Proteomic Clocks Correlates with Risk of Mortality and Age-Related Disease
Key Takeaways
  • A combined proteomic age gap score associated with smoking, alcohol use, and physical inactivity.
  • Proteomic age acceleration predicted higher risk of mortality and cardiovascular disease and dementia.
  • Organ-specific proteomic clocks showed stronger associations with related cancers such as lung and kidney cancer.
Read the full article at Fight Aging!

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.